Drug-Diagnostics Co-Development in Oncology
The idea of combining drugs and diagnostics in oncology is not new. When the selective estrogen receptor modulator tamoxifen was developed in the 1970's for the treatment of breast cancer a positive correlation between receptor status and treatment outcome was found. As a result of this researc...
Saved in:
Main Author: | Jan Trost Jorgensen (auth) |
---|---|
Format: | Electronic Book Chapter |
Language: | English |
Published: |
Frontiers Media SA
2014
|
Series: | Frontiers Research Topics
|
Subjects: | |
Online Access: | DOAB: download the publication DOAB: description of the publication |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
Published: (2020) -
Roles of MET in Cancer Development and Treatment
Published: (2023) -
Diagnostic Devices with Microfluidics
Published: (2017) -
Diagnostic Devices with Microfluidics
Published: (2017) -
Emerging Translational Opportunities in Comparative Oncology with Companion Canine Cancers
Published: (2020)